INFU vs RJF · P/E 25, rev $70.6M vs rev $15.91B
InfuSystems Holdings Inc (INFU) versus RJF (RJF) — a side-by-side from cached financials, not a winner call.
InfuSystems Holdings Inc (INFU) is a medical devices company listed on US.
RJF (RJF) common stock.
Latest reported INFU revenue for 2026-06-30 was $70.6M. Net income was $4.2M. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
INFU currently screens at market cap $186.5M and trailing P/E 25.0. RJF currently screens at market cap $0.
Not investment advice. Open the INFU and RJF stock pages for the full models.
Not investment advice.